uveiti
visuallydebilit
disord
affect
children
juvenil
idiopath
arthriti
jia
identifi
genet
suscept
loci
uveiti
jia
conduct
genomewid
associ
studi
compar
jiaassoci
uveiti
case
jia
individu
without
uveiti
two
cohort
jia
patient
underw
genotyp
qualiti
control
use
hlaspecif
imput
panel
imput
hlaspecif
amino
acid
hla
type
identifi
amino
acid
serin
posit
associ
increas
risk
uveiti
p
x
signal
femalespecif
interact
sex
p
resid
ystmotif
posit
peptid
bind
groov
quantit
bind
affin
predict
reveal
peptidebind
prefer
distinguish
allotyp
ystmotif
find
highlight
genet
distinct
sexuallydimorph
featur
jiaassoci
uveiti
juvenil
idiopath
arthriti
jia
common
chronic
rheumat
diseas
childhood
affect
approxim
per
individu
mani
children
suffer
common
jia
categori
oligoarticular
polyarticular
rheumatoid
factorneg
jia
develop
uveiti
chronic
inflammatori
eye
diseas
frequent
extraarticular
manifest
jia
uveiti
threaten
sight
affect
result
complic
includ
macular
edema
band
keratopathi
cataract
glaucoma
hypotoni
typic
afflict
young
year
old
uveiti
dramat
impact
qualiti
life
childhood
adult
earli
detect
adequ
ophthalmolog
manag
jiaassoci
uveiti
critic
prevent
signific
sightthreaten
complic
despit
sever
uveiti
typic
insidi
onset
often
becom
symptomat
irrevers
damag
occur
consequ
rigor
ophthalmolog
screen
jia
patient
requir
earli
detect
treatment
uveiti
associ
jia
nonetheless
sever
ocular
complic
may
alreadi
present
time
uveiti
diagnosi
sever
clinic
factor
associ
increas
uveiti
risk
young
age
year
old
jia
onset
presenc
antinuclear
antibodi
ana
elev
erythrocyt
sediment
rate
esr
jia
onset
jia
categori
oligoarticular
polyarticular
rheumatoid
factor
rf
neg
sex
also
consid
risk
factor
though
avail
epidemiolog
data
controversi
femal
patient
compris
major
jia
categori
uveiti
therefor
observ
somewhat
frequent
modestli
overal
jia
popul
extent
biolog
risk
jiaassoci
uveiti
sexual
dimorph
howev
known
jia
jiaassoci
uveiti
ie
jiauveiti
multifactori
autoimmun
disord
strong
though
fulli
penetr
genet
predisposit
condit
complex
driven
biolog
environment
factor
report
observ
mendelian
inherit
pattern
uveiti
jiaaffect
famili
indic
complex
trait
architectur
genomewid
associ
studi
jia
individu
without
uveiti
reveal
number
loci
associ
diseas
includ
multipl
independ
loci
major
histocompat
complex
mhc
collect
explain
phenotyp
variat
broadlydefin
jia
number
hla
type
also
identifi
increas
risk
jiaassoci
uveiti
compar
control
howev
genomewid
genet
marker
distinguish
jia
without
uveiti
jiaassoci
uveiti
remain
elus
exact
diseas
mechan
predispos
subgroup
children
develop
uveiti
unknown
due
sever
uveiti
complic
surround
detect
biomark
predict
develop
uveiti
would
help
earli
detect
presenc
jiauveiti
highrisk
children
without
frequent
extens
costli
screen
jia
patient
perform
genotyp
jiaassoci
uveiti
case
jia
patient
without
uveiti
least
year
aim
identifi
genet
variant
segreg
commonli
jia
patient
uveiti
compar
without
uveiti
sampl
analys
fall
follow
intern
leagu
associ
rheumatolog
ilar
categori
oligoarticular
extend
ii
oligoarticular
persist
iii
rfneg
polyarticular
jia
analyz
collect
jiauveiti
categori
one
group
increas
power
common
categori
jia
particularli
prone
uveiti
recent
shown
genet
highli
similar
hla
associ
identifi
risk
variant
highdens
set
polymorph
perform
two
set
imput
one
use
sequencingbas
refer
panel
scan
riskincreas
allel
genomewid
second
mhcspecif
refer
panel
identifi
addit
snp
amino
acid
hla
type
confer
risk
diseas
identifi
serin
posit
highli
associ
increas
risk
uveiti
odd
ratio
ci
p
x
sexspecif
analysi
reveal
associ
specif
femal
p
femal
x
p
male
quantit
predict
peptid
bind
reveal
presenc
locat
peptidebind
groov
affect
overal
peptidebind
prefer
common
allotyp
perform
analysi
two
phase
jointli
analyz
improv
power
locu
discoveri
phase
genotyp
jiaassoci
uveiti
case
nonuv
jia
sampl
populationlevel
control
without
jia
uveiti
collect
within
netherland
sampl
genotyp
array
contain
marker
sampl
snp
underw
qualiti
control
qc
materi
method
remov
sampl
snp
lowqual
genotyp
data
qc
jiaassoci
uveiti
case
nonuv
jia
sampl
populationlevel
control
remain
tabl
prephas
genotyp
data
use
imput
phase
haplotyp
use
refer
panel
construct
global
sampl
includ
genom
project
phase
parallel
genomewid
imput
extract
mhc
genotyp
data
imput
addit
snp
amino
acid
hla
type
use
pipelin
materi
method
phase
addit
jiaassoci
uveiti
case
jia
without
uveiti
sampl
total
n
collect
germani
belgium
switzerland
genotyp
array
sampl
snp
underw
qc
nearli
ident
phase
materi
method
qc
jiaassoci
uveiti
case
nonuv
jia
sampl
remain
analysi
clean
genotyp
data
prephas
imput
genomewid
within
mhc
precis
phase
genomewid
associ
test
phase
phase
data
kept
snp
minor
allel
frequenc
maf
imput
qualiti
score
variant
avail
phase
phase
imput
filter
snp
phase
phase
respect
info
score
supplementari
tabl
mhc
associ
test
analyz
variant
maf
imput
qualiti
filter
appli
mhcspecif
imput
data
mhc
variant
phase
phase
respect
imput
qualiti
score
supplementari
tabl
perform
genomewid
associ
test
across
autosom
genom
use
logist
regress
framework
assum
addit
model
plink
correct
sex
first
two
princip
compon
supplementari
figur
data
enabl
three
possibl
comparison
group
jia
case
populationlevel
control
b
jiaassoci
uveiti
case
populationlevel
control
c
jiaassoci
uveiti
case
nonuv
jia
goal
analysi
investig
similar
differ
genet
architectur
jia
uveiti
far
larger
gwa
jia
populationlevel
control
alreadi
perform
perform
first
two
genomewid
associ
studi
gwa
mean
data
qualiti
control
supplementari
figur
account
consid
multipl
test
burden
focu
result
last
comparison
jiaassoci
uveiti
case
nonuv
jia
sampl
perform
separ
gwa
phase
phase
combin
summarylevel
result
invers
varianceweight
fix
effect
metaanalysi
metal
combin
analysi
nonuv
jia
sampl
uveiti
case
combin
data
rather
perform
separ
discoveri
replic
phase
improv
power
discoveri
novel
associ
signal
genomewid
scan
singl
signal
achiev
genomewid
signific
set
p
x
adjust
three
phenotyp
comparison
resid
mhc
supplementari
figur
identifi
amino
acid
hla
type
drive
genomewid
associ
signal
perform
megaanalysi
across
imput
mhc
data
first
merg
imput
dosag
phase
phase
use
plink
perform
logist
regress
assum
addit
model
correct
top
princip
compon
sex
analysi
phase
ie
phase
phase
megaanalysi
approach
theoret
empir
highli
similar
invers
varianceweight
metaanalysi
also
perform
metaanalysi
across
phase
phase
found
inde
odd
ratio
deriv
megaanalysi
metaanalysi
mhc
highli
concord
pearson
r
supplementari
figur
megaanalysi
allow
addit
advantag
allow
interact
test
condit
analysi
associ
variant
across
full
dataset
omnibu
test
one
allel
present
posit
compar
null
model
found
goodnessoffit
omnibu
test
far
exceed
null
model
includ
sex
princip
compon
genotyp
batch
likelihood
ratio
test
p
x
test
singl
posit
allel
drive
top
associ
signal
oppos
possibl
allel
togeth
model
omnibu
test
condit
top
associ
signal
first
serin
aspart
acid
posit
includ
dosag
respect
variant
addit
covari
logist
regress
model
figur
tabl
supplementari
tabl
tabl
deciph
specif
residu
drive
associ
uveiti
perform
seri
likelihood
ratio
test
brief
likelihood
ratio
test
compar
fit
two
model
observ
data
indic
model
either
best
fit
data
found
amino
acid
best
fit
data
p
x
compar
model
contain
pc
sex
independ
variabl
includ
sg
residu
posit
well
yst
motif
modestli
improv
fit
model
likelihood
ratio
test
p
compar
model
contain
serin
posit
neither
g
residu
alon
posit
improv
model
p
test
recent
mhc
finemap
studi
jia
categori
test
map
primari
diseas
associ
signal
g
residu
posit
addit
identifi
independ
risk
serin
posit
analyz
jia
patient
without
uveiti
also
observ
associ
supplementari
tabl
sought
disentangl
previouslydescrib
associ
signal
jia
residu
g
posit
jiaassoci
uveiti
signal
residu
posit
observ
adjust
either
g
posit
jiaassoci
uveiti
vs
nonuv
jia
analysi
found
signal
moder
affect
adjust
ci
p
x
adjust
ci
p
x
result
indic
associ
signal
uveiti
fulli
explain
jiaassoci
amino
acid
posit
sinc
uveiti
epidemiolog
known
preval
femal
oligoarticular
jia
want
formal
test
primari
signal
uveiti
show
evid
sexual
dimorph
sampl
test
femal
sampl
found
genomewid
signific
signal
ci
p
x
found
evid
associ
male
sampl
ci
p
tabl
figur
consequ
yield
nearli
ident
associ
tabl
explor
potenti
sexspecif
effect
posit
ran
associ
test
across
sampl
includ
interact
term
sex
imput
dosag
found
signific
effect
interact
term
ci
p
indic
signal
inde
sexspecif
effect
polymorph
beta
chain
specifi
peptid
bind
prefer
hladr
molecul
serin
posit
well
adjac
associ
amino
acid
posit
locat
bottom
antigenbind
groov
protein
figur
suggest
differ
peptidebind
prefer
may
confer
risk
develop
uveiti
explor
presenc
serin
posit
affect
peptidemhcii
interact
compar
predict
bind
affin
common
allotyp
repres
allel
case
use
larg
panel
peptid
base
human
iri
proteom
data
materi
method
supplementari
tabl
use
netmhciipan
server
briefli
neural
networkbas
netmhciipan
algorithm
capabl
reliabl
detect
differ
peptidebind
repertoir
highli
similar
mhc
class
ii
molecul
identifi
allel
encod
protein
similar
predict
bind
prefer
perform
unsupervis
hierarch
cluster
cluster
peptid
affin
data
discern
two
major
cluster
classic
allel
strikingli
similar
distribut
serin
posit
supplementari
figur
observ
averag
bind
affin
peptid
panel
higher
allel
encod
serin
posit
versu
allel
amino
acid
posit
wilcoxon
signedrank
test
p
x
supplementari
tabl
compar
two
cluster
comput
ratio
averag
bind
affin
allotyp
contain
amino
acid
posit
supplementari
tabl
sinc
mhc
class
ii
molecul
cell
surfac
present
ccbynd
intern
licens
made
avail
repertoir
skew
favor
high
affin
binder
select
peptid
ic
affin
nm
affin
nm
routin
use
threshold
potenti
immunogen
strong
bind
peptid
allotyp
materi
method
data
indic
peptid
intermedi
high
affin
allotyp
contain
less
affin
allotyp
contain
amino
acid
posit
supplementari
tabl
number
hla
type
amino
acid
posit
demonstr
associ
jia
uveiti
relat
autoimmun
diseas
genomewid
associ
candid
gene
studi
look
previouslyassoci
hla
type
amino
acid
gwa
jia
unaffect
control
uveiti
unaffect
control
seven
associ
appear
data
associ
nomin
signific
p
supplementari
tabl
supplementari
figur
interrog
imput
hla
type
amino
acid
identifi
amino
acid
serin
posit
gene
strongli
associ
increas
risk
uveiti
femal
patient
jia
associ
indic
though
jia
uveiti
jia
without
uveiti
share
clinic
featur
genet
risk
factor
particular
hlaspecif
genet
risk
factor
genet
architectur
specif
uveiti
specif
use
condit
test
likelihood
ratio
test
show
previous
report
signal
jia
posit
distinct
signal
uveiti
signal
posit
find
suggest
two
phenotyp
like
biolog
featur
progress
partial
distinct
associ
test
initi
reveal
either
serin
aspart
acid
posit
mostassoci
variant
signal
determin
primarili
driven
serin
howev
perfect
linkag
disequilibrium
serin
tyrosin
posit
threonin
posit
make
imposs
disentangl
three
amino
acid
statist
framework
subset
amino
acid
three
ystmotif
may
key
diseas
onset
importantli
though
three
residu
locat
bottom
peptidebind
groov
posit
toward
thu
like
interact
bind
peptid
epitop
figur
previou
work
identifi
strongest
risk
factor
seroneg
rheumatoid
arthriti
ra
jia
patient
includ
uveiti
might
categor
seroneg
ra
time
reach
adulthood
seroneg
ra
consid
genet
mirror
uveitispron
jia
categori
contrast
highli
protect
seroposit
ra
biolog
distinct
form
ra
uveiti
common
case
sexspecif
analys
mhc
reveal
signal
uniqu
femal
sampl
interact
sex
genotyp
signific
associ
signal
entir
absent
analysi
restrict
male
sampl
reduc
number
case
n
male
jiauveiti
case
n
male
nonuv
jia
control
therefor
reduc
power
maleonli
analysi
may
explain
absenc
signal
howev
power
detect
associ
p
maleonli
analysi
assum
odd
ratio
male
femal
assum
modest
effect
male
still
power
detect
signal
p
detect
potenti
subtl
effect
male
larger
case
collect
necessari
improv
power
nonetheless
interact
test
sex
provid
compel
evid
sexuallydimorph
signal
indepth
data
sexspecif
epidemiolog
uveiti
associ
jia
spars
howev
typic
bilater
chronic
anterior
uveiti
report
occur
frequent
femal
genotypebysex
interact
inform
excit
field
futur
research
aim
elucid
uveiti
risk
mechan
underli
signal
may
mediat
sexspecif
factor
hormon
regul
sexspecif
pattern
genet
associ
may
help
resolv
previous
report
evid
sexual
dimorph
respect
sever
diseas
cours
children
jiaassoci
uveiti
lastli
find
indic
sex
stratif
may
benefici
futur
clinic
trial
therapeut
agent
may
efficaci
femal
male
like
mhc
class
ii
molecul
essenti
immun
orchestr
downstream
immun
respons
present
dynam
cargo
thousand
differ
peptid
scrutini
helper
cell
jia
uveiti
consid
diseas
mediat
helper
cell
subset
strong
associ
amino
acid
motif
tag
suggest
predetermin
peptid
prefer
may
affect
regul
helper
cell
investig
immunolog
impact
motif
use
revers
immunolog
approach
materi
method
perform
use
data
protein
experiment
observ
human
iri
sinc
jiauveiti
patient
frequent
circul
ana
direct
iri
tissu
specif
focus
nuclear
protein
provid
diseaserelev
dataset
model
although
larg
panel
put
antigen
test
mean
exhaust
supplementari
tabl
experi
demonstr
presenc
motif
accompani
distinguish
chang
bind
affin
result
protein
supplementari
tabl
supplementari
figur
suggest
antigen
present
protein
may
underpin
uveiti
suscept
risk
allel
encod
eg
supplementari
tabl
may
commun
distinct
peptidom
influenc
helper
cell
significantli
increas
likelihood
downstream
immun
respons
eg
ana
eye
anaposit
modestli
correl
presenc
case
studi
pearson
r
p
function
studi
use
hlaproteom
approach
necessari
experiment
valid
systemat
dissect
complex
downstream
effect
tissuespecif
antigen
present
uveiti
rel
high
frequenc
jia
case
develop
uveiti
tabl
indic
like
involv
addit
epi
genet
environment
factor
inde
gene
outsid
mhc
implic
jiauveiti
includ
ccbynd
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
polymorph
variant
near
immun
gene
half
patient
jiauveiti
display
elev
titer
antiparvoviru
antibodi
ocular
fluid
human
parvoviru
infect
caus
variou
clinic
featur
includ
arthriti
uveiti
ana
product
addit
immun
infect
strongli
associ
involv
helper
cell
observ
collect
outlin
complex
interplay
biolog
environment
factor
jiauveiti
though
abl
identifi
associ
collect
jiauveiti
jia
without
uveiti
sampl
analys
leav
unansw
question
genet
underpin
uveiti
potenti
sexbas
differ
pathogenesi
given
sampl
size
well
power
detect
common
frequenc
highlypenetr
odd
ratio
supplementari
figur
variat
associ
increas
uveiti
risk
compar
jia
individu
without
uveiti
howev
underpow
identifi
common
modestlypenetr
variat
hallmark
genet
featur
complex
phenotyp
may
distinguish
two
phenotyp
current
studi
includ
patient
abl
obtain
detail
ophthalmolog
followup
year
uveiti
develop
within
year
onset
imper
reveal
associ
strategi
limit
case
ascertain
futur
genet
studi
like
benefit
broader
inclus
case
includ
essenti
detail
phenotyp
inform
order
identifi
addit
genet
associ
share
across
distinct
particular
uveiti
subtyp
gender
addit
clinic
studi
includ
clinic
trial
may
improv
wellpow
sex
enabl
sexspecif
investig
much
progress
made
understand
biolog
jia
understand
genet
landscap
uveiti
limit
hand
candid
gene
studi
hlaspecif
analys
investig
uveiti
phenotyp
separ
jia
recent
gwa
identifi
risk
factor
uveiti
recent
studi
jiaassoci
uveiti
point
toward
role
infiltr
plasma
cell
helper
cell
chang
ocular
fluid
microenviron
futur
larger
genet
studi
compar
jiauveiti
jia
without
uveiti
without
sexspecif
analysi
like
expand
understand
uveiti
pathogenesi
number
way
broad
case
inclus
elucid
whether
subtypespecif
architectur
exist
larger
sampl
improv
statist
power
identifi
modesteffect
diseasemodifi
variant
within
outsid
mhc
exampl
may
substanti
associ
addit
hla
allel
uveiti
jia
figur
larger
studi
may
also
help
reveal
clinicallyus
biomark
risk
factor
young
age
presenc
ana
assum
reflect
aberr
immun
activ
indic
patient
potenti
higher
risk
uveiti
way
predict
diseas
outcom
easilytest
biomark
genotyp
would
highli
impact
manag
uveiti
would
help
overcom
challeng
detect
insidi
onset
diseas
intriguingli
deeper
examin
phenotyp
data
found
femal
uveiti
case
studi
carri
least
one
copi
variant
code
femal
uveiti
case
carri
appear
suffer
ananeg
oligoarthr
mild
vitriti
peripher
multifoc
choroid
absenc
anterior
segment
inflamm
ocular
find
atyp
jia
thu
accord
inclus
criteria
sampl
like
improperli
includ
cohort
collect
prospect
studi
larger
popul
includ
detail
clinic
evalu
develop
uveiti
secondari
uveiti
phenotyp
necessari
dissect
potenti
genotyp
biomark
diseas
risk
regardless
current
studi
justifi
genet
analysi
potenti
power
instrument
move
analysi
genet
architectur
uveiti
toward
accur
effici
clinic
decis
tool
result
studi
repres
key
step
understand
pathogenesi
uveiti
jia
help
discern
biolog
share
distinct
featur
jiauveiti
jia
without
uveiti
futur
work
allow
us
disentangl
two
phenotyp
evalu
share
distinct
diseas
etiolog
unravel
pathogenesi
two
diseas
improv
understand
key
pathway
trigger
diseas
pinpoint
understand
mechan
potenti
identifi
clinicallyus
biomark
stratifi
patient
diseas
risk
order
improv
person
care
catalyz
futur
line
research
precis
medicin
collect
work
advanc
progress
toward
treat
prevent
sightthreaten
complic
uveiti
children
jia
ccbynd
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
total
patient
oligoarticular
extend
oligoarticular
persist
rheumatoid
factor
neg
polyarticular
jia
develop
uveiti
enrol
studi
patient
collect
two
independ
cohort
dutch
cohort
cohort
compris
sampl
collect
germani
belgium
switzerland
simplic
refer
phase
phase
sampl
set
respect
threehundr
eighti
four
patient
includ
phase
sampl
uveiti
sampl
patient
includ
phase
sampl
uveiti
sampl
genotyp
data
unrel
unaffect
dutch
sampl
use
popul
control
previous
genotyp
use
platform
jia
uveiti
sampl
contain
studi
inform
jia
subtyp
sex
uveiti
statu
collect
patient
presenc
antinuclear
antibodi
ana
could
collect
major
patient
sampl
includ
phase
studi
approv
local
institut
review
board
complianc
helsinki
principl
inform
consent
obtain
particip
patient
year
older
parent
patient
year
age
parent
younger
year
old
sampl
genotyp
use
infinium
array
contain
snp
phase
jia
case
without
uveiti
genotyp
togeth
unaffect
control
genotyp
array
separ
batch
phase
sampl
genotyp
togeth
perform
imput
ran
samplelevel
snplevel
data
qualiti
control
follow
standard
genomewid
associ
qualiti
control
step
step
threshold
number
remov
sampl
snp
summar
supplementari
tabl
briefli
use
plink
first
check
samplelevel
missing
across
sampl
remov
sampl
missing
next
remaind
samplelevel
qualiti
control
reduc
dataset
highqual
snp
snp
minor
allel
frequenc
maf
snp
outsid
mhc
chromosom
lactas
locu
chromosom
invers
chromosom
snp
missing
snp
linkag
disequilibrium
ld
prune
ld
r
threshold
highqual
set
snp
perform
princip
compon
analysi
pca
use
eigenstrat
defin
sampl
european
ancestri
princip
compon
pc
pc
valu
within
standard
deviat
europeanancestri
popul
includ
hapmap
dataset
ceu
popul
sampl
northern
western
european
ancestri
live
utah
tsi
popul
toscan
live
itali
addit
calcul
inbreed
coeffici
sampl
remov
sampl
standard
deviat
distribut
relat
sampl
pihat
also
remov
final
use
snp
avail
chromosom
x
perform
sex
check
identifi
sampl
mismatch
genotyp
phenotyp
sex
sampl
mismatch
genotyp
phenotyp
inform
remov
analysi
drop
fail
sampl
data
proceed
perform
snp
qc
snp
missing
remov
snp
frequenc
rare
analyz
logist
regress
framework
given
sampl
size
snp
hardyweinberg
equilibrium
control
across
full
dataset
remov
p
x
phase
p
x
phase
snp
signific
differenti
missing
case
control
p
x
phase
p
x
phase
sampleand
snplevel
qc
complet
fail
sampl
snp
remov
data
perform
second
iter
pca
ensur
case
control
overlap
pca
space
ie
obviou
popul
stratif
data
supplementari
figur
prephas
sampleand
snplevel
complet
phase
phase
data
phase
separ
genotyp
qc
separ
use
sampl
size
sampl
prephas
run
without
refer
panel
per
recommend
follow
prephas
imput
sampl
use
imput
refer
panel
construct
wholegenom
sequenc
sampl
genom
project
phase
briefli
genom
project
phase
data
compris
sampl
collect
america
africa
east
asia
europ
south
asia
sampl
wholegenom
sequenc
coverag
across
exom
coverag
nonexom
region
imput
prephas
haplotyp
use
data
phase
window
megabas
long
buffer
region
set
effect
sampl
size
ne
per
recommend
set
khap
sampl
european
ancestri
genom
phase
imput
refer
panel
contain
haplotyp
europeanancestri
individu
imput
amino
acid
hla
allel
mhc
use
pipelin
short
pipelin
use
refer
panel
assembl
hla
type
europeanancestri
individu
collect
type
diabet
genet
consortium
panel
includ
snp
amino
acid
mhc
well
hla
type
class
hlaa
hlab
hlac
class
ii
hla
gene
hla
type
imput
resolut
pipelin
use
beagl
phase
data
imput
postimput
check
sum
dosag
across
hla
gene
individu
sampl
dosag
one
hla
gene
induc
imprecis
imput
drop
analysi
perform
genomewid
associ
test
code
jia
sampl
uveiti
case
jia
sampl
without
uveiti
control
first
perform
genomewid
associ
studi
gwa
phase
phase
individu
check
overal
behavior
genomewid
test
statist
lambda
lambda
gwa
perform
use
plink
use
addit
logist
regress
model
correct
top
two
princip
compon
sex
data
metaanalyz
use
metal
ensur
analyz
snp
highqual
imput
analyz
common
ccbynd
intern
licens
made
avail
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
snp
maf
imput
qualiti
info
score
phase
data
addit
gwa
perform
compar
sampl
jia
uveiti
unaffect
control
well
jia
sampl
without
uveiti
unaffect
control
result
concord
studi
previous
perform
phenotyp
supplementari
tabl
similar
genomewid
associ
test
addit
logist
regress
phase
phase
data
first
perform
separ
check
overal
behavior
data
dosag
merg
togeth
logist
regress
perform
dosag
data
use
correct
top
princip
compon
sex
phase
ensur
megaanalysi
approach
appropri
addit
perform
invers
varianceweight
metaanalysi
two
phase
found
result
highli
concord
pearson
r
genomewid
beta
identifi
potenti
independ
signal
within
mhc
perform
followup
regress
condit
topmost
variant
figur
proteom
data
human
iri
tissu
nonredund
protein
use
repres
sourc
protein
present
iri
tissu
jiauveiti
patient
commonli
antinuclear
antibodi
ana
direct
iri
tissu
thu
focus
nuclear
iri
protein
gener
potenti
diseaserelev
dataset
protein
access
number
extract
filter
uniprot
univers
protein
resourc
protein
subcellular
locat
annot
limit
nucleu
select
protein
supplementari
tabl
fulfil
criteria
full
length
amino
acid
sequenc
fed
neural
network
server
netmhciipan
algorithm
select
high
qualiti
perform
peptid
bind
predict
mhc
class
ii
allel
sequenc
identifi
includ
experiment
peptid
bind
affin
limit
allelespecif
train
data
avail
ascertain
test
predict
bind
affin
sever
hundr
experiment
identifi
peptid
ligand
elut
reveal
correctli
pick
netmhciipan
ligand
ic
data
shown
next
test
predict
affin
overlap
peptid
select
protein
tent
could
present
hladr
bind
repres
fourdigit
allel
allel
account
allel
jia
case
affin
data
logtransform
valu
use
ic
nm
log
categor
allotyp
allel
similar
predict
bind
prefer
perform
unsupervis
hierarch
cluster
heatmap
creat
base
euclidean
distanc
measur
ward
linkag
method
use
metaboanalyst
server
comput
ratio
averag
bind
affin
molecul
contain
peptidebind
groov
averag
bind
affin
protein
amino
acid
posit
measur
overal
differ
predict
bind
affin
peptid
frequenc
distribut
ratio
bind
affin
plot
entir
set
peptid
includ
low
nonbind
peptid
potenti
ligand
bind
affin
stronger
half
maxim
inhibitori
concentr
ic
nm
peptid
high
bind
affin
encod
allel
ic
correspond
presenc
given
amino
acid
residu
presenc
serin
ser
aspart
acid
asp
posit
imput
info
score
top
hit
initi
associ
test
condit
either
aspart
acid
serin
reveal
amino
acid
posit
wellimput
imput
info
perfect
linkag
disequilibrium
explain
bulk
initi
signal
associ
statist
tyrosin
posit
threonin
posit
serin
glycin
posit
ident
associ
statist
report
serin
posit
due
linkag
disequilibrium
molecul
posit
provid
view
top
peptidebind
groov
betachain
highlight
orang
amino
acid
serin
posit
red
locat
bottom
center
peptidebind
groov
adjac
amino
acid
tyrosin
posit
green
threonin
posit
blue
serin
posit
display
sphere
structur
produc
use
ucsf
chimera
